Pre Next

[1] FANG Bangjiang, WU Xinxin ZHANG Wen CAO Min GUO Quan HUANG Tingrong ZHOU Shuang LI Jinhua REN Yi7 SHAO Zhong8 PENG Wei LIU Li,.Theory and Practice of COVID-19 Treatment with Truncation and Reverse “Resolving Both Exterior and Interior” Method Based on TCM Epidemic Theory [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2022, (04): 1-7. [doi: 10.13424/j.cnki.jsctcm.2022.04.001]

Copy

Theory and Practice of COVID-19 Treatment with Truncation and Reverse “Resolving Both Exterior and Interior” Method Based on TCM Epidemic Theory

Journal of Shaanxi University of Traditional Chinese Medicine[ISSN: 2096-1340/ CN: 61-1501/R] Volumes & Issues: 2022 04 pagination: 1-7 Column: Publication date: 2022-07-20

Article number:: 2096-1340(2022)04-0001-07

Author(s):: FANG Bangjiang¹; 2; 3; WU Xinxin¹ ZHANG Wen¹ CAO Min¹ GUO Quan¹ HUANG Tingrong⁴ ZHOU Shuang⁵ LI Jinhua⁶ REN Yi⁷ SHAO Zhong⁸ PENG Wei¹ LIU Li³

Keywords:: Key words： Epidemic disease; COVID-19; Resolving both exterior and interior; Truncation and reverse; Traditional Chinese Medicine

ZTFLH:: R254.3?

DOI:: 10.13424/j.cnki.jsctcm.2022.04.001

Code:: A

Abstract:: Abstract： COVID19 belongs to the category of “epidemic disease” in traditional Chinese medicine. According to the epidemic disease theory of traditional Chinese medicine, on the basis of inheriting the theory of treating infectious diseases with traditional Chinese medicine such as the theory of febrile disease, and drawing lessons from the academic experience of treating infectious diseases of professor ZHU Liangchun and Professor CHAO Enxiang, both masters of traditional Chinese medicine, and aiming at the characteristics of TCM Syndromes of COVID19, at the beginning of the outbreak of COVID19 in 2020, the academic concept of “resolving both exterior and interior” for the treatment of COVID19 was put forward, and the “resolving both exterior and interior” of “eliminating dampness through the surface and purging toxin” and “clearing heat and diuresis” were advocated to cut off and reverse the disease of patients infected with COVID19. The results of treatment of mild and common COVID19 in COVID19 designated hospitals during the outbreak of the epidemic in Wuhan and Shanghai showed that this treatment could shorten the time of nucleic acid negative transformation of patients,blocking the transformation of COVID19 to severe and critical diseases has a significant effect, which opens up a new idea for the treatment of COVID19 with traditional Chinese medicine and the prevention and treatment of new sudden infectious diseases in the future.

References:

［1］World Health Organization.Coronavirus disease (COVID19) situation reports［EB/OL］.(2022-05-31)［2021-05-31］.https://covid19.who.int/.
［2］国家卫生健康委员会.新型冠状病毒肺炎诊疗方案（试行第九版）［EB/OL］.(2022-03-15)［2022-03-15］.http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba 4494583805a3d2e40093d88/files/ef09aa4070244620b010951b088b8a27.pdf.
［3］方邦江,齐文升,黄烨.新型冠状病毒感染的肺炎中西医结合防控手册［M］.北京:人民卫生出版社,2020:65-67.
［4］Fang BJ,Zhang W,Wu XX,et al.Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19):study protocol for an openlabel randomized controlled clinical trial［J］.Trials,2020,21(1):568.
［5］Wu XX,Lu W,Guo Q,et al.Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on “Internal and External RelievingTruncated Torsion” strategy［J］.Medicine,2020,99(51):e23874.
［6］方邦江,李灿辉,陈业孟,等.中医疫病学实践和理论的发展创新:中外专家谈新型冠状病毒肺炎中医治疗启示［J］.中国中西医结合杂志,2020,40(11):12851290.
［7］Wu XX,Zhou S,Liu CY,et al.Clinical predictive risk factors prolonged the duration of SARS-CoV-2 clearance in 279 moderate COVID-19 patients:a multicenter retrospective cohort study［J］.Medicine,2021,100(40):e27410.
［8］包兆含,张文,邬鑫鑫,等.“截断扭转扶正固本”法治疗疫病思想对新型冠状病毒肺炎救治的启示［J］.中国中医急症,2020,29(8):1320-1322.
［9］方邦江,齐文升,杨志旭,等.《新型冠状病毒肺炎诊疗方案(试行第九版)》中医治疗更新及其对奥密克戎变异株感染防治指导作用［J］.陕西中医药大学学报,2022,45(3):1-4.
［10］吴有性.温疫论［M］.北京: 中国医药科技出版社，2018．
［11］王孟英.温热经纬［M］.北京: 人民卫生出版社，2005．
［12］杨璇.伤寒温疫条辨［M］.北京: 学苑出版社，2006.
［13］吴鞠通.温病条辨［M］．北京：学苑出版社，2017.
［14］方邦江,周爽.国医大师朱良春治疗疑难危急重症经验集［M］.北京:中国中医药出版社,2013.
［15］方邦江,张洪春.国医大师晁恩祥治疗危急疑难重症学术经验［M］.北京:人民卫生出版社,2020.
［16］van Eijk LE,Binkhorst M,Bourgonje AR,et al.COVID19:immunopathology,pathophysiological mechanisms,and treatment options［J］.The Journal of Pathology,2021,254(4):307-331.
［17］方邦江,张文,周爽,等.基于“急性虚证”理论防治新型冠状病毒肺炎探析［J］.中医杂志,2021,62(9):826-828.
［18］Zhou S,Feng J,Xie Q,et al.Traditional Chinese medicine Shenhuang Granule in patients with severe/critical COVID19:a randomized controlled multicenter trial［J］.Phytomedicine,2021,89:153612.
［19］鲍建敏.基于“肺与大肠相表里”再认识的新型冠状病毒肺炎治疗［J］.浙江中医药大学学报,2020,44(6):500-506.
［20］陈晓蓉,方邦江.中西医结合诊疗新型冠状病毒肺炎验案120例［M］.上海:上海科学技术出版社,2020.
［21］中国国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第九版)［J］.国际流行病学传染病学杂志,2022,49(2):73-80.
［22］方邦江,苏红,赵软金,等.新型冠状病毒奥密克戎变异株感染中医药防治专家共识［J］.中国急救医学,2022,42(4):277-280.
［23］周选堂.时病论歌括新编［M］.武汉:湖北科学技术出版社,1987.
［24］周爽,卜建宏,孙丽华.方邦江治疗急重疑难病证学术经验［M］.北京:中国中医药出版社,2018:27-28.
［25］张向红,程黎晖.大黄的药理作用及临床应用研究进展［J］.中国药业,2009,18(21):76-78.
［26］王琳,王丽,吴建鹏,等.大黄治疗危重症胃肠功能受损患者的疗效观察［J］.中国中医急症,2021,30(10):1805-1808.
［27］Keser S,Keser F,Karatepe M,et al.Bioactive contents,in vitro antiradical,antimicrobial and cytotoxic properties of rhubarb (Rheum ribes L.) extracts［J］.Natural Product Research,2019,34(23):3353-3357.
［28］王志洁,邓培,方学韫,等.虎杖蒽醌化合物抗疱疹病毒的实验研究［J］.湖北医科大学学报,2000,21(3):180-183.
［29］谢扬,张勇,刘瑞源.虎杖及其复方制剂抗病毒有效成分研究与临床应用［J］.时珍国医国药,2004,15(8):527.
［30］邓艳,刘洪,吴新玉,等.虎杖苷的保肝作用研究进展［J］.中国比较医学杂志,2021,31(9):136-140.
［31］李志军.“三证三法”及“菌毒炎并治”治疗脓毒症的研究进展［J］.中国中西医结合外科杂志,2012,18(6):553-554.
［32］牛颖,章学林,方邦江,等.锦红汤对急性胆源性感染全身性炎症反应综合征的调节作用［J］.中国中西医结合杂志,2004,24(8):707-709.
［33］朱玲,赵平,李萍,等.加味锦红汤联合西医常规疗法治疗脓毒症临床研究［J］.上海中医药杂志,2014,48(10):57-59.
［34］黄明,杨丰文,张磊,等.中医药治疗新型冠状病毒肺炎的经验与策略:张伯礼院士武汉一线抗疫思考［J］.中医杂志,2020,61(24):2117-2120.

Memo

基金项目：国家重点研发计划（2018YFC1705900）；上海市科学技术委员会科研计划项目（19401933300）；国家中医药管理局2022年第五批新型冠状病毒感染肺炎中医药应急专项课题（2022ZYLCYJ05-4）；上海中医药大学2022年度应对奥密克戎感染新型冠状病毒（2022YJ-03、2022YJ-06）

Last Update: 2022-07-25